{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T02:40:25Z","timestamp":1792809625623,"version":"4.5.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,6,27]],"date-time":"2012-06-27T00:00:00Z","timestamp":1340755200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2012,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The transcription factor SOX11 is of diagnostic and prognostic importance in mantle cell lymphoma (MCL) and epithelial ovarian cancer (EOC), respectively. Thus, there is an unmet clinical and experimental need for SOX11-targeting assays with low background, high specificity and robust performance in multiple applications, including immunohistochemistry (IHC-P) and flow cytometry, which until now has been lacking.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We have developed SOX11-C1, a monoclonal mouse antibody targeting SOX11, and successfully evaluated its performance in western blots (WB), IHC-P, fluorescence microscopy and flow cytometry.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>We confirm the importance of SOX11 as a diagnostic antigen in MCL as 100% of tissue micro array (TMA) cases show bright nuclear staining, using the SOX11-C1 antibody in IHC-P. We also show that previous reports of weak SOX11 immunostaining in a fraction of hairy cell leukemias (HCL) are not confirmed using SOX11-C1, which is consistent with the lack of transcription. Thus, high sensitivity and improved specificity are demonstrated using the monoclonal SOX11-C1 antibody. Furthermore, we show for the first time that flow cytometry can be used to separate SOX11 positive and negative cell lines and primary tumors. Of note, SOX11-C1 shows no nonspecific binding to primary B or T cells in blood and thus, can be used for analysis of B and T cell lymphomas from complex clinical samples. Dilution experiments showed that low frequencies of malignant cells (~1%) are detectable above background using SOX11 as a discriminant antigen in flow cytometry.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>The novel monoclonal SOX11-specific antibody offers high sensitivity and improved specificity in IHC-P based detection of MCL and its expanded use in flow cytometry analysis of blood and tissue samples may allow a convenient approach to early diagnosis and follow-up of MCL patients.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2407-12-269","type":"journal-article","created":{"date-parts":[[2012,6,27]],"date-time":"2012-06-27T16:29:24Z","timestamp":1340814564000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Expanded clinical and experimental use of SOX11 - using a monoclonal antibody"],"prefix":"10.1186","volume":"12","author":[{"given":"Lena","family":"Nordstr\u00f6m","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrika","family":"Andr\u00e9asson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mats","family":"Jerkeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Dictor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl","family":"Borrebaeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Ek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,6,27]]},"reference":[{"issue":"2","key":"3373_CR1","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1182\/blood-2007-06-093401","volume":"111","author":"S Ek","year":"2008","unstructured":"Ek S, Dictor M, Jerkeman M, Jirstrom K, Borrebaeck CA: Nuclear expression of the non B-cell lineage Sox11 transcription factor identifies mantle cell lymphoma. Blood. 2008, 111 (2): 800-805. 10.1182\/blood-2007-06-093401.","journal-title":"Blood"},{"issue":"2","key":"3373_CR2","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1111\/j.1365-2141.2008.07329.x","volume":"143","author":"X Wang","year":"2008","unstructured":"Wang X, Asplund AC, Porwit A, Flygare J, Smith CI, Christensson B, Sander B: The subcellular Sox11 distribution pattern identifies subsets of mantle cell lymphoma: correlation to overall survival. Br J Haematol. 2008, 143 (2): 248-252. 10.1111\/j.1365-2141.2008.07329.x.","journal-title":"Br J Haematol"},{"issue":"11","key":"3373_CR3","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.3324\/haematol.2009.010264","volume":"94","author":"A Mozos","year":"2009","unstructured":"Mozos A, Royo C, Hartmann E, De Jong D, Baro C, Valera A, Fu K, Weisenburger DD, Delabie J, Chuang SS, et al: SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype. Haematologica. 2009, 94 (11): 1555-1562. 10.3324\/haematol.2009.010264.","journal-title":"Haematologica"},{"issue":"4","key":"3373_CR4","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1158\/0008-5472.CAN-09-3419","volume":"70","author":"V Fernandez","year":"2010","unstructured":"Fernandez V, Salamero O, Espinet B, Sole F, Royo C, Navarro A, Camacho F, Bea S, Hartmann E, Amador V, et al: Genomic and gene expression profiling defines indolent forms of mantle cell lymphoma. Cancer Res. 2010, 70 (4): 1408-1418. 10.1158\/0008-5472.CAN-09-3419.","journal-title":"Cancer Res"},{"issue":"1","key":"3373_CR5","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/modpathol.2009.140","volume":"23","author":"YH Chen","year":"2010","unstructured":"Chen YH, Gao J, Fan G, Peterson LC: Nuclear expression of sox11 is highly associated with mantle cell lymphoma but is independent of t(11;14)(q13;q32) in non-mantle cell B-cell neoplasms. Mod Pathol. 2010, 23 (1): 105-112. 10.1038\/modpathol.2009.140.","journal-title":"Mod Pathol"},{"issue":"2","key":"3373_CR6","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1097\/PAS.0b013e318241f050","volume":"36","author":"W Zeng","year":"2012","unstructured":"Zeng W, Fu K, Quintanilla-Fend L, Lim M, Ondrejka S, Hsi ED: Cyclin D1-negative Blastoid Mantle Cell Lymphoma Identified by SOX11 Expression. Am J Surg Pathol. 2012, 36 (2): 214-219. 10.1097\/PAS.0b013e318241f050.","journal-title":"Am J Surg Pathol"},{"issue":"8","key":"3373_CR7","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1016\/j.ejca.2009.01.028","volume":"45","author":"DJ Brennan","year":"2009","unstructured":"Brennan DJ, Ek S, Doyle E, Drew T, Foley M, Flannelly G, O'Connor DP, Gallagher WM, Kilpinen S, Kallioniemi OP, et al: The transcription factor Sox11 is a prognostic factor for improved recurrence-free survival in epithelial ovarian cancer. Eur J Cancer. 2009, 45 (8): 1510-1517. 10.1016\/j.ejca.2009.01.028.","journal-title":"Eur J Cancer"},{"key":"3373_CR8","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1186\/1471-2407-11-405","volume":"11","author":"S Sernbo","year":"2011","unstructured":"Sernbo S, Gustavsson E, Brennan DJ, Gallagher WM, Rexhepaj E, Rydnert F, Jirstrom K, Borrebaeck CA, Ek S: The tumour suppressor SOX11 is associated with improved survival among high grade epithelial ovarian cancers and is regulated by reversible promoter methylation. BMC Cancer. 2011, 11: 405-10.1186\/1471-2407-11-405.","journal-title":"BMC Cancer"},{"issue":"6","key":"3373_CR9","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1093\/nar\/27.6.1409","volume":"27","author":"M Wegner","year":"1999","unstructured":"Wegner M: From head to toes: the multiple facets of Sox proteins. Nucleic Acids Res. 1999, 27 (6): 1409-1420. 10.1093\/nar\/27.6.1409.","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"3373_CR10","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1111\/j.1460-9568.2009.06768.x","volume":"29","author":"A Haslinger","year":"2009","unstructured":"Haslinger A, Schwarz TJ, Covic M: Chichung Lie D: Expression of Sox11 in adult neurogenic niches suggests a stage-specific role in adult neurogenesis. Eur J Neurosci. 2009, 29 (11): 2103-2114. 10.1111\/j.1460-9568.2009.06768.x.","journal-title":"Eur J Neurosci"},{"issue":"15","key":"3373_CR11","doi-asserted-by":"publisher","first-page":"6635","DOI":"10.1128\/MCB.24.15.6635-6644.2004","volume":"24","author":"E Sock","year":"2004","unstructured":"Sock E, Rettig SD, Enderich J, Bosl MR, Tamm ER, Wegner M: Gene targeting reveals a widespread role for the high-mobility-group transcription factor Sox11 in tissue remodeling. Mol Cell Biol. Biol 2004, 24 (15): 6635-6644.","journal-title":"Mol Cell Biol"},{"issue":"2","key":"3373_CR12","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1006\/geno.1995.9970","volume":"29","author":"P Jay","year":"1995","unstructured":"Jay P, Goze C, Marsollier C, Taviaux S, Hardelin JP, Koopman P, Berta P: The human SOX11 gene: cloning, chromosomal assignment and tissue expression. Genomics. 1995, 29 (2): 541-545. 10.1006\/geno.1995.9970.","journal-title":"Genomics"},{"issue":"2","key":"3373_CR13","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/(SICI)1097-0177(199710)210:2<79::AID-AJA1>3.0.CO;2-6","volume":"210","author":"M Hargrave","year":"1997","unstructured":"Hargrave M, Wright E, Kun J, Emery J, Cooper L, Koopman P: Expression of the Sox11 gene in mouse embryos suggests roles in neuronal maturation and epithelio-mesenchymal induction. Dev Dyn. 1997, 210 (2): 79-86. 10.1002\/(SICI)1097-0177(199710)210:2<79::AID-AJA1>3.0.CO;2-6.","journal-title":"Dev Dyn"},{"issue":"24","key":"3373_CR14","doi-asserted-by":"publisher","first-page":"3475","DOI":"10.1101\/gad.403406","volume":"20","author":"M Bergsland","year":"2006","unstructured":"Bergsland M, Werme M, Malewicz M, Perlmann T, Muhr J: The establishment of neuronal properties is controlled by Sox4 and Sox11. Genes Dev. 2006, 20 (24): 3475-3486. 10.1101\/gad.403406.","journal-title":"Genes Dev"},{"issue":"5","key":"3373_CR15","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1093\/dnares\/6.5.357","volume":"6","author":"T Azuma","year":"1999","unstructured":"Azuma T, Ao S, Saito Y, Yano K, Seki N, Wakao H, Masuho Y, Muramatsu M: Human SOX11, an upregulated gene during the neural differentiation, has a long 3' untranslated region. DNA Res. 1999, 6 (5): 357-360. 10.1093\/dnares\/6.5.357.","journal-title":"DNA Res"},{"issue":"11","key":"3373_CR16","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.3324\/haematol.2009.008474","volume":"94","author":"M Dictor","year":"2009","unstructured":"Dictor M, Ek S, Sundberg M, Warenholt J, Gyorgy C, Sernbo S, Gustavsson E, Abu-Alsoud W, Wadstrom T, Borrebaeck C: Strong lymphoid nuclear expression of SOX11 transcription factor defines lymphoblastic neoplasms, mantle cell lymphoma and Burkitt's lymphoma. Haematologica. 2009, 94 (11): 1563-1568. 10.3324\/haematol.2009.008474.","journal-title":"Haematologica"},{"issue":"8","key":"3373_CR17","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.3324\/haematol.2010.036277","volume":"96","author":"SL Ondrejka","year":"2011","unstructured":"Ondrejka SL, Lai R, Smith SD, Hsi ED: Indolent mantle cell leukemia: a clinicopathological variant characterized by isolated lymphocytosis, interstitial bone marrow involvement, kappa light chain restriction, and good prognosis. Haematologica. 2011, 96 (8): 1121-1127. 10.3324\/haematol.2010.036277.","journal-title":"Haematologica"},{"key":"3373_CR18","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/1476-4598-9-187","volume":"9","author":"E Gustavsson","year":"2010","unstructured":"Gustavsson E, Sernbo S, Andersson E, Brennan DJ, Dictor M, Jerkeman M, Borrebaeck CA, Ek S: SOX11 expression correlates to promoter methylation and regulates tumor growth in hematopoietic malignancies. Mol Cancer. 2010, 9: 187-10.1186\/1476-4598-9-187.","journal-title":"Mol Cancer"},{"issue":"6","key":"3373_CR19","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.molonc.2011.08.001","volume":"5","author":"P Conrotto","year":"2011","unstructured":"Conrotto P, Andreasson U, Kuci V, Borrebaeck CA, Ek S: Knock-down of SOX11 induces autotaxin-dependent increase in proliferation in vitro and more aggressive tumors in vivo. Mol Oncol. 2011, 5 (6): 527-537. 10.1016\/j.molonc.2011.08.001.","journal-title":"Mol Oncol"},{"issue":"6","key":"3373_CR20","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1002\/1097-0142(19820915)50:6<1122::AID-CNCR2820500616>3.0.CO;2-Q","volume":"50","author":"LW Diamond","year":"1982","unstructured":"Diamond LW, Nathwani BN, Rappaport H: Flow cytometry in the diagnosis and classification of malignant lymphoma and leukemia. Cancer. 1982, 50 (6): 1122-1135. 10.1002\/1097-0142(19820915)50:6<1122::AID-CNCR2820500616>3.0.CO;2-Q.","journal-title":"Cancer"},{"key":"3373_CR21","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1746-1596-3-43","volume":"3","author":"AM El-Sayed","year":"2008","unstructured":"El-Sayed AM, El-Borai MH, Bahnassy AA, El-Gerzawi SM: Flow cytometric immunophenotyping (FCI) of lymphoma: correlation with histopathology and immunohistochemistry. Diagn Pathol. 2008, 3: 43-10.1186\/1746-1596-3-43.","journal-title":"Diagn Pathol"},{"issue":"1","key":"3373_CR22","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1002\/cyto.a.10101","volume":"58","author":"RC Braylan","year":"2004","unstructured":"Braylan RC: Impact of flow cytometry on the diagnosis and characterization of lymphomas, chronic lymphoproliferative disorders and plasma cell neoplasias. Cytometry A. 2004, 58 (1): 57-61.","journal-title":"Cytometry A"},{"issue":"5517","key":"3373_CR23","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/256495a0","volume":"256","author":"G Kohler","year":"1975","unstructured":"Kohler G, Milstein C: Continuous cultures of fused cells secreting antibody of predefined specificity. Nature. 1975, 256 (5517): 495-497. 10.1038\/256495a0.","journal-title":"Nature"},{"issue":"1","key":"3373_CR24","first-page":"139","volume":"13","author":"B Weigle","year":"2005","unstructured":"Weigle B, Ebner R, Temme A, Schwind S, Schmitz M, Kiessling A, Rieger MA, Schackert G, Schackert HK, Rieber EP: Highly specific overexpression of the transcription factor SOX11 in human malignant gliomas. Oncol Rep. 2005, 13 (1): 139-144.","journal-title":"Oncol Rep"},{"issue":"3","key":"3373_CR25","doi-asserted-by":"publisher","first-page":"197","DOI":"10.2144\/000113382","volume":"48","author":"J Bordeaux","year":"2010","unstructured":"Bordeaux J, Welsh A, Agarwal S, Killiam E, Baquero M, Hanna J, Anagnostou V, Rimm D: Antibody validation. Biotechniques. 2010, 48 (3): 197-209. 10.2144\/000113382.","journal-title":"Biotechniques"},{"issue":"2","key":"3373_CR26","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1097\/PAI.0b013e31804c7283","volume":"15","author":"NS Goldstein","year":"2007","unstructured":"Goldstein NS, Hewitt SM, Taylor CR, Yaziji H, Hicks DG: Recommendations for improved standardization of immunohistochemistry. Appl Immunohistochem Mol Morphol. 2007, 15 (2): 124-133. 10.1097\/PAI.0b013e31804c7283.","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"2","key":"3373_CR27","doi-asserted-by":"crossref","first-page":"289","DOI":"10.5858\/2001-125-0289-APAFEN","volume":"125","author":"ED Hsi","year":"2001","unstructured":"Hsi ED: A practical approach for evaluating new antibodies in the clinical immunohistochemistry laboratory. Arch Pathol Lab Med. 2001, 125 (2): 289-294.","journal-title":"Arch Pathol Lab Med"},{"issue":"2","key":"3373_CR28","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1007\/s12032-011-9937-5","volume":"29","author":"X Cao","year":"2011","unstructured":"Cao X, Fan L, Fang C, Zhu DX, Dong HJ, Wang DM, Wang YH, Xu W, Li JY: The expression of SOX11, cyclin D1, cyclin D2, and cyclin D3 in B-cell lymphocytic proliferative diseases. Med Onco. 2011, 29 (2): 1190-1196.","journal-title":"Med Onco"},{"issue":"10","key":"3373_CR29","doi-asserted-by":"crossref","first-page":"3847","DOI":"10.1002\/j.1460-2075.1993.tb06063.x","volume":"12","author":"M van de Wetering","year":"1993","unstructured":"van de Wetering M, Oosterwegel M, van Norren K, Clevers H: Sox-4, an Sry-like HMG box protein, is a transcriptional activator in lymphocytes. EMBO J. 1993, 12 (10): 3847-3854.","journal-title":"EMBO J"},{"issue":"2","key":"3373_CR30","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2302\/kjm.60.37","volume":"60","author":"T Yamada","year":"2011","unstructured":"Yamada T: Therapeutic monoclonal antibodies. Keio J Med. 2011, 60 (2): 37-46. 10.2302\/kjm.60.37.","journal-title":"Keio J Med"},{"issue":"2","key":"3373_CR31","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0145-2126(00)00114-4","volume":"25","author":"MO Elnenaei","year":"2001","unstructured":"Elnenaei MO, Jadayel DM, Matutes E, Morilla R, Owusu-Ankomah K, Atkinson S, Titley I, Mandala EM, Catovsky D: Cyclin D1 by flow cytometry as a useful tool in the diagnosis of B-cell malignancies. Leuk Res. 2001, 25 (2): 115-123. 10.1016\/S0145-2126(00)00114-4.","journal-title":"Leuk Res"},{"issue":"12","key":"3373_CR32","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1136\/jcp.55.12.940","volume":"55","author":"P Jain","year":"2002","unstructured":"Jain P, Giustolisi GM, Atkinson S, Elnenaei MO, Morilla R, Owusu-Ankomah K, Rafiq-Mohammed F, Matutes E, Wotherspoon A, Catovsky D: Detection of cyclin D1 in B cell lymphoproliferative disorders by flow cytometry. J Clin Pathol. 2002, 55 (12): 940-945. 10.1136\/jcp.55.12.940.","journal-title":"J Clin Pathol"},{"issue":"4","key":"3373_CR33","doi-asserted-by":"publisher","first-page":"551","DOI":"10.3324\/haematol.11267","volume":"93","author":"S Bottcher","year":"2008","unstructured":"Bottcher S, Ritgen M, Buske S, Gesk S, Klapper W, Hoster E, Hiddemann W, Unterhalt M, Dreyling M, Siebert R, et al: Minimal residual disease detection in mantle cell lymphoma: methods and significance of four-color flow cytometry compared to consensus IGH-polymerase chain reaction at initial staging and for follow-up examinations. Haematologica. 2008, 93 (4): 551-559. 10.3324\/haematol.11267.","journal-title":"Haematologica"},{"issue":"6","key":"3373_CR34","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1074\/mcp.M300022-MCP200","volume":"2","author":"C Agaton","year":"2003","unstructured":"Agaton C, Galli J, Hoiden Guthenberg I, Janzon L, Hansson M, Asplund A, Brundell E, Lindberg S, Ruthberg I, Wester K, et al: Affinity proteomics for systematic protein profiling of chromosome 21 gene products in human tissues. Mol Cell Proteomics. 2003, 2 (6): 405-414.","journal-title":"Mol Cell Proteomics"},{"issue":"6","key":"3373_CR35","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1074\/mcp.M600077-MCP200","volume":"5","author":"S Ek","year":"2006","unstructured":"Ek S, Andreasson U, Hober S, Kampf C, Ponten F, Uhlen M, Merz H, Borrebaeck CA: From gene expression analysis to tissue microarrays: a rational approach to identify therapeutic and diagnostic targets in lymphoid malignancies. Mol Cell Proteomics. 2006, 5 (6): 1072-1081. 10.1074\/mcp.M600077-MCP200.","journal-title":"Mol Cell Proteomics"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-12-269.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-12-269\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-12-269","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-12-269.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T20:29:26Z","timestamp":1630614566000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-12-269"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6,27]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["3373"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-12-269","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6,27]]},"assertion":[{"value":"13 February 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"269"}}